Is this email not displaying correctly? View it in your browser.
Customer Quarterly Newsletter | September 2014

Therapist Focus

Catherine Arnault.

I have been a massage therapist for 30 years and have practised lymphoedema therapy for 15 years.

How long have you been using the LTU-904:
I was introduced to the RianCorp laser during a Vodder recertification 5 or 6 years ago.

Most inspiring or intriguing laser story:
Recently I had good results with a seroma.

What do you use the laser for:
At first I was using it for lymphoedema treatments. But as I also have a lot of post surgery clients (cosmetic, reconstruction or just knee and hip replacement) I use it for inflammation, scars, fibrosis, always in conjunction with other equipment, with positive results.

Then I started reading the book of Jan Tuner and Lars Hode: "The New laser Therapy". I have since been experimenting on acupuncture points (as I was also trained in acupuncture).

Nowadays I try to spend more time with the laser on a specific areas, to check what conditions seem to respond better.

I have came across others lasers but keep my RianCorp laser as it seems steady, reliable and has been used for studies.

We have to accept that a number of treatments are usually required, but I use it on any possible conditions. And so far, I am very pleased.

Important note

The LTU-904 is the only laser registered with the American FDA and the Australian TGA specifically for lymphoedema treatment. Many LLLT devices generate heat and are registered as heat lamps – making them unsuitable for lymphoedema treatment.

New Research


Jastifer JR, Catena F, Doty JF, Stevens F, Coughlin MJ


BACKGROUND: Plantar fasciitis affects nearly 1 million people annually in the United States. Traditional nonoperative management is successful in about 90% of patients, usually within 10 months. Chronic plantar fasciitis develops in about 10% of patients and is a difficult clinical problem to treat. A newly emerging technology, low-level laser therapy (LLLT), has demonstrated promising results for the treatment of acute and chronic pain.

METHODS: Thirty patients were administered LLLT and completed 12 months of follow-up. Patients were treated twice a week for 3 weeks for a total of 6 treatments and were evaluated at baseline, 2 weeks post procedure, and 6 and 12 months post procedure. Patients completed the Visual Analog Scale (VAS) and Foot Function Index (FFI) at study follow-up periods.

RESULTS: Patients demonstrated a mean improvement in heel pain VAS from 67.8 out of 100 at baseline to 6.9 out of 100 at the 12-month follow-up period. Total FFI score improved from a mean of 106.2 at baseline to 32.3 at 12 months post procedure.

CONCLUSION: Although further studies are warranted, this study shows that LLLT is a promising treatment of chronic plantar fasciitis.

LEVEL OF EVIDENCE: Level 4, case series.

Retrieved from:



Pereira TS, Flecha OD, Guimaraes RC, de Oliveira D, Botelho AM, Ramos Gloria JC, Aguiar Tavano KT


AIM: Low-level laser therapy has still not been well established, and it is important to define a standardized protocol for the treatment of temporomandibular disorders (TMDs) using low level laser. There is no consensus on controlled clinical trials concerning the best option for laser therapy with regard to wavelength. The aim of this study was to evaluate the efficacy of red and infrared laser therapy in patients with TMD, using a randomized parallel-group double-blind trial.

METHODOLOGY: Each hemiface of 19 subjects was randomized to receive intervention, in a total of 116 sensitive points. Pain was measured at baseline and time intervals of 24 hours, 30 days, 90 days, and 180 days after treatment. Irradiation of 4 J/cm2 in the temporomandibular joints and 8 J/cm(2) in the muscles was used in three sessions.

RESULTS: Both treatments had statistically significant results (P<0.001); there was statistical difference between them at 180 days in favor of the infrared laser (P=0.039). There was improvement in 24 hours, which extended up to 180 days in both groups.

CONCLUSION: Both lasers are effective in the treatment and remission of TMD symptoms.

Retrieved from:


Copyright © 2014, All rights reserved.
You're receiving this email because you are a valued customer of RianCorp, or you have opted in to our mailing list.

Our mailing address is: PO Box 177, Marleston, SA 5033 Australia